Product Reports Resources Pricing Login Book a demo

Seagen

Biotech & Life Sciences · Bothell, United States · Founded 1998 · IPO 2001

A global biotechnology company dedicated to developing revolutionary therapies with real impact

Valuation $42B
Revenue $2.30B

Talent graph

Seagen's talent

Book a demo to see the people
Employees mapped 708 incl. 4 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 30 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

5 investors on Seagen's cap table

Sourced from Dealroom's funding and investor records.

Series A 3 investors entered at this stage
Indosuez Ventures
Sofinnova Investments
OVP Venture Partners
Series B+ 2 investors entered at this stage
International Biotechnology Trust
Scale Venture Partners

Global footprint

Where Seagen has talent and traffic

Workforce by country
13 countries with
team presence
🇺🇸 United States91%
🇨🇭 Switzerland2.7%
🇫🇷 France1.8%
🇩🇪 Germany0.8%
🇬🇧 United Kingdom0.6%
Top 5 of 13 shown

Patent intelligence

Seagen’s patent portfolio

Estimated portfolio value
$277M

169 active families in the valuation dataset.

Source: Dealroom Patent Intelligence · PatSnap. Portfolio estimates and the family records below have different coverage.

Compare patent portfolios across companies →

Capital deployed

Seagen's 4 investments and acquisitions.

Every disclosed deal where Seagen appeared as a backer or acquirer, 2015–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

4 deals across Seagen's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        02 · Portfolio market map

        Seagen's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        4 of 4 deals

        Market sentiment

        What the market is saying about Seagen

        An AI-synthesized read of the highest-engagement posts about Seagen on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Seagen on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.